Compare TDOC & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDOC | TLRY |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.2M | 919.2M |
| IPO Year | 2015 | 2018 |
| Metric | TDOC | TLRY |
|---|---|---|
| Price | $5.29 | $7.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 4 |
| Target Price | $7.40 | ★ $103.33 |
| AVG Volume (30 Days) | ★ 5.7M | 2.4M |
| Earning Date | 05-25-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,406,840,000.00 | N/A |
| Revenue This Year | $1.74 | $7.39 |
| Revenue Next Year | $1.24 | $4.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.41 | N/A |
| 52 Week Low | $4.40 | $0.36 |
| 52 Week High | $9.77 | $15.70 |
| Indicator | TDOC | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 43.92 |
| Support Level | $4.44 | $7.11 |
| Resistance Level | $5.49 | $8.20 |
| Average True Range (ATR) | 0.27 | 0.38 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 80.02 | 41.46 |
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.